Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study

Charles V. Pollack^*, Richard A Bernstein, Robert Dubiel, Paul Reilly, Fredrik Gruenenfelder, Menno V. Huisman, Chak Wah Kam, Eva Kleine, Jerrold H. Levy, Frank W. Sellke, Thorsten Steiner, Anastasia Ustyugova, Jeffrey I. Weitz

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

1 results
- Title
- Start date(ascending)

Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study
Pollack, C. V. (Creator), Bernstein, R. (Creator), Dubiel, R. (Creator), Reilly, P. (Creator), Gruenenfelder, F. (Creator), Huisman, M. V. (Creator), Kam, C.-W. (Contributor), Kleine, E. (Creator), Levy, J. H. (Creator), Sellke, F. W. (Creator), Steiner, T. (Creator), Ustyugova, A. (Creator) & Weitz, J. I. (Creator), Taylor & Francis, 2017
DOI: 10.6084/m9.figshare.4476206.v2, https://tandf.figshare.com/articles/dataset/Healthcare_resource_utilization_in_patients_receiving_idarucizumab_for_reversal_of_dabigatran_anticoagulation_due_to_major_bleeding_urgent_surgery_or_procedural_interventions_interim_results_from_the_RE-VERSE_AD_sup_sup_study/4476206/2
Dataset